Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  For the Patient  |  Careers at Hemispherx  


 

Corporate Governance

The following documents are provided in Adobe Acrobat PDF format:

Audit Committee Charter Click Here
Compensation Committee Charter Click Here
Corporate Governance Guidelines Click Here
Corporate Governance Nominating Charter Click Here
Disclosure Controls Committee Charter Click Here
Stock Ownership Guidelines Click Here

Additional Documents:
Hemispherx Code of Ethics - Click Here
Employee 401(k) Summary - Click Here

 
Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.